Article Data

  • Views 631
  • Dowloads 44

Brief Report

Open Access

Vulnerability of People with Cancer and the Potential Risks of COVID-19 Pandemic: A perspective in Morocco

  • Rachid Ait Addi1
  • Abdelhafid Benksim1,2
  • Mohamed Cherkaoui2

1Laboratory of Human Ecology, Department of Biology, School of Sciences Semlalia, Cadi Ayyad University, Marrakech, Morocco

2High Institute of Nursing and Technical Health, Marrakech, Morocco

DOI: 10.22514/sv.2020.16.0030 Vol.16,Issue 1,June 2020 pp.207-208

Published: 30 June 2020

*Corresponding Author(s): Rachid Ait Addi E-mail: dr.rachid.aitaddi@gmail.com

PDF (135.38 kB)

Abstract

Cancer affects almost 18 million around the world in 2018, of these 9.5 million cases were in men and 8.5 million in women. COVID-19 is an acute respiratory disease caused by novel coronavirus SARS-CoV-2 or 2019-nCoV and was first reported in Wuhan, China in December 2019. Recently, on March 11, 2020, COVID-19 was declared by the World Health Organization (WHO) as a virus pandemic disease. Furthermore, it has been known that the malignancy and anticancer treatments, such as chemotherapy or surgery cause systemic immunosuppressive state in patients with cancer which exposes them to infection more than others especially for COVID-19 and with a high probability of complications. Additionally, the major concern for patients with cancer is the incapacity to get fundamental medical services due to the pandemic spread. In Morocco, thanks to measures such as contamination prevention, prioritization of care, and price control of therapies, cancer patients were able to continue their treatment during the covid-19 pandemic.

Key words

COVID-19, Cancer, Pandemic, Morocco

Cite And Share

Rachid Ait Addi,Abdelhafid Benksim,Mohamed Cherkaoui. Vulnerability of People with Cancer and the Potential Risks of COVID-19 Pandemic: A perspective in Morocco. Signa Vitae. 2020. 16(1);207-208.

References

[1] Worldwide cancer data Global. Cancer statistics for the most common cancers. https://www.wcrf.org/dietandcancer/cancer-trends/worldwide-cancer-data.

[2] National Cancer Institute. Risk Factors for Cancer. https://www. cancer.gov/about-cancer/causes-prevention/risk.

[3] Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, and Jemal

A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394-424.

[4] National Cancer Institute.Cancer Treatment. https://www. cancer.gov/about-cancer/treatment.

[5] Ait Addi R, Benksim A, Amine M, Cherkaoui M. COVID-19 Outbreak and Perspective in Morocco. Electron J Gen Med. 2020;17:em204.

[6] Gao Y, Li T, Han M, et al. Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID‐19. J Med Virol. 2020;1–6.

[7] Bai Y, Yao L, Wei T, et al. Presumed Asymptomatic Carrier Transmission of COVID-19. JAMA. 2020;323:1406-1407.

[8] Kruse RL. Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan,China. 1000Res. 2020;9:72.

[9] Centers for disease control and prevention. Coronavirus Disease 2019 (COVID-19) : People Who Are At Higher Risk. https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/groups-at-higher-risk.html.

[10] Lambertini M, Toss A, Passaro A, et al. Cancer care during the spread of coronavirus disease 2019 (COVID-19) in Italy: young oncologists’ perspective. ESMO Open. 2020;5:e000759.

[11] Hanping Wang, Li Zhang. Risk of COVID-19 for patients with cancer. Lancet oncol. 2020;21:E181.

[12] Liang W, Guan W, Chen R, Wang W, Li J, Xu K, Li C, Ai Q, Lu W, Liang H, Li S, He J. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21:335-337.

[13] Cortiula F, Pettke A, Bartoletti M, Puglisi F, Helleday T. Managing COVID-19 in the oncology clinic and avoiding the distraction effect. Ann Oncol. 2020;31:553‐555.

[14] Rivera A, Ohri N, Thomas E, Miller R, Knoll MA. The Impact of COVID-19 on Radiation Oncology Clinics and Cancer Patients in the U.S. Adv Radiat Oncol. 2020. doi:10.1016/j.adro.2020.03.006.

[15] Yuen E, Fote G, Horwich P, et al. Head and neck cancer care in the COVID-19 pandemic: A brief update. Oral Oncol. 2020;105:104738.

[16] Hanna TP, Evans GA, Booth CM. Cancer, COVID-19 and the precautionary principle: prioritizing treatment during a global. Nat Rev Clin Oncol. 2020;17:268-270.

[17] Lu H, Zhao B, Zhang J, et al. Does delayed initiation of adjuvant chemotherapy following the curative resection affect the survival outcome of gastric cancer patients: A systematic review and meta-analysis [published online ahead of print, 2020 Jan 8]. Eur J Surg Oncol. 2020;S0748-7983:30017-2.

[18] Covid-19/Maroc : Ne pas oublier les patients atteints de cancer du poumon. https://fr.hespress.com/142811-covid-19-maroc-ne-pas-oublier-les-patients-\atteints-de-cancer-du-poumon.html.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) The Science Citation Index (SCI) is a citation index originally produced by the Institute for Scientific Information (ISI) and created by Eugene Garfield. It (Science Citation Index Expanded) covers more than 8,500 notable and significant journals, across 150 disciplines in science and technology, from 1900 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Chemical Abstracts Service Source Index The CAS Source Index (CASSI) Search Tool is an online resource that can quickly identify or confirm journal titles and abbreviations for publications indexed by CAS since 1907, including serial and non-serial scientific and technical publications.

IndexCopernicus The Index Copernicus International (ICI) Journals database’s is an international indexation database of scientific journals. It covered international scientific journals which divided into general information, contents of individual issues, detailed bibliography (references) sections for every publication, as well as full texts of publications in the form of attached files (optional). For now, there are more than 58,000 scientific journals registered at ICI.

Geneva Foundation for Medical Education and Research The Geneva Foundation for Medical Education and Research (GFMER) is a non-profit organization established in 2002 and it works in close collaboration with the World Health Organization (WHO). The overall objectives of the Foundation are to promote and develop health education and research programs.

Scopus Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.

Embase Embase (often styled EMBASE for Excerpta Medica dataBASE), produced by Elsevier, is a biomedical and pharmacological database of published literature designed to support information managers and pharmacovigilance in complying with the regulatory requirements of a licensed drug.

Submission Turnaround Time

Conferences

    Top